Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Gerald DialDirector | Open-market buy | 25/12/30 | 06/01 | 10,000 sh | $0.76 | $7,600 | +500.0% | |
David J. CroyleChief Medical Officer | Open-market buy | 03/20 | 03/26 | 10,195 sh | $1.75 | $17,841.25 | +1.3% | |
David J. CroyleChief Medical Officer | Open-market buy | 03/06 | 03/10 | 14,805 sh | $1.76 | $26,056.8 | +1.9% | |
| Open-market buy | 25/12/30 | 01/06 | 2,000 sh2 trades | $1.20avg. | $2,409.22 | No record | ||
Wayne D. WilliamsCEO, Chairman and President | Open-market buy | 25/12/16 | 25/12/18 | 5,000 sh | $1.73 | $8,650 | +6.3% | |
| Open-market buy | 25/12/11–25/12/15 | 25/12/15 | 15,798 sh3 trades | $1.72avg. | $27,108.48 | No record | ||
| Open-market buy | 25/12/10–25/12/11 | 25/12/12 | 44,545 sh2 trades | $1.65avg. | $73,499.25 | +185.6% | ||
| Open-market buy | 25/12/08–25/12/09 | 25/12/10 | 1,512 sh2 trades | $1.54avg. | $2,334.24 | No record | ||
David J. CroyleChief Medical Officer | Open-market buy | 25/03/27 | 25/04/03 | 25,000 sh | $4.50 | $112,500 | +3.3% | |
| Open-market buy | 25/02/05 | 25/03/14 | 63,125 sh3 trades | $4.00avg. | $252,500 | No record | ||
David J. CroyleChief Medical Officer | Open-market buy | 25/02/05 | 25/03/14 | 24,375 sh | $4.00 | $97,500 | No record |